Skip to Main Content (Press Enter)

Logo UNISR
  • ×
  • Home
  • People
  • Outputs
  • Organizations
  • Expertise & Skills

UNIFIND
Logo UNISR

|

UNIFIND

unisr.it
  • ×
  • Home
  • People
  • Outputs
  • Organizations
  • Expertise & Skills
  1. Outputs

Correction to: Sequential Treatment of Sorafenib–Regorafenib Versus Sorafenib–Physician’s Choice: A Propensity Score-Matched Analysis (Targeted Oncology, (2021), 16, 3, (401-410), 10.1007/s11523-021-00797-3)

Academic Article
Publication Date:
2021
abstract:
The listing of the author names and affiliations, which previously read:.
Iris type:
1.1 Articolo in rivista
List of contributors:
Bang, Y.; Yoo, C.; Lonardi, S.; Kim, H. -D.; Vivaldi, C.; Rimini, M.; Frassineti, G. L.; Park, S. R.; Rizzato, M. D.; Ryu, M. -H.; Salani, F.; Rapposelli, I. G.; Ryoo, B. -Y.; Zagonel, V.; Massa, V.; Valgiusti, M.; Burgio, V.; Scartozzi, M.; Cascinu, S.; Casadei-Gardini, A.
Authors of the University:
CASADEI GARDINI ANDREA
CASCINU STEFANO
RIMINI MARGHERITA
Handle:
https://iris.unisr.it/handle/20.500.11768/125269
Published in:
TARGETED ONCOLOGY
Journal
  • Use of cookies

Powered by VIVO | Designed by Cineca | 26.6.0.0